Roles of tetrahydrobiopterin in promoting tumor angiogenesis

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2671-2680

  Chen, Liye ^a   Zeng, Xin ^a   Wang, Jihui ^a   Briggs, Simon S ^a   O'Neill, Eric ^b   Li, Jiliang ^a   Leek, Russell ^a   Kerr, David J ^c   Harris, Adrian L ^a   Cai, Shijie ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PTERIN; RAS PROTEIN; SEPIAPTERIN; TETRAHYDROBIOPTERIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 78149309463     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100025     Document Type: Article

References (49)

1. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257
2. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA: Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 2005, 102:13147-13152
3. Heller R, Polack T, Grabner R, Till U: Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis 1999, 144:49-57
4. Fukumura D, Kashiwagi S, Jain RK: The role of nitric oxide in tumour progression. Nat Rev Cancer 2006, 6:521-534
5. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1999, 1411:217-230
6. Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D: NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest 2005, 115:1816-1827
7. Brouet A, DeWever J, Martinive P, Havaux X, Bouzin C, Sonveaux P, Feron O: Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide. FASEB J 2005, 19:602-604
8. Lin MI, Yu J, Murata T, Sessa WC: Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res 2007, 67:2849-2856
9. Ng QS, Goh V, Milner J, Stratford MR, Folkes LK, Tozer GM, Saunders MI, Hoskin PJ: Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol 2007, 8:111-118
10. Fulton D, Gratton JP, Sessa WC: Posttranslational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001, 299:818-824
11. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601
12. Lim KH, Ancrile BB, Kashatus DF, Counter CM: Tumour maintenance is mediated by eNOS. Nature 2008, 452:646-649
13. Ibiza S, Perez-Rodriguez A, Ortega A, Martinez-Ruiz A, Barreiro O, Garcia-Dominguez CA, Victor VM, Esplugues JV, Rojas JM, Sanchez-Madrid F, Serrador JM: Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci USA 2008, 105:10507-10512
14. Harrison DG: Cellular and molecular mechanisms of endothelial dysfunction. J Clin Invest 1998, 100:2153-2157
15. Cai S, Alp NJ, Mc Donald D, Canevari L, Heales S, Channon KM: GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerization. Cardiovasc Res 2002, 55:838-849
16. Cai S, Khoo J, Channon KM: Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res 2005, 65:823-831
17. Lowndes SA, Sheldon HV, Cai S, Taylor JM, Harris AL: Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvasc Res 2009, 77:314-326
18. Marinos RS, Zhang W, Wu G, Kelly KA, Meininger CJ: Tetrahydrobiopterin levels regulate endothelial cell proliferation. Am J Physiol Heart Circ Physiol 2001, 281:H482-H489
19. Michaelis M, Michaelis R, Suhan T, Schmidt H, Mohamed A, Doerr HW, Cinatl J, Jr.: Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion. FASEB J 2007, 21:81-87
20. Thony B, Auerbach G, Blau N: Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000, 347(Pt. 1):1-16
21. Du YH, Guan YY, Alp NJ, Channon KM, Chen AF: Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 2008, 117:1045-1054
22. Sugiyama T, Levy BD, Michel T: Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem 2009, 284:12691-12700
23. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW, Jr., de la Chapelle A, Frankel WL: Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004, 23:7366-7377
24. Murr C, Widner B, Wirleitner B, Fuchs D: Neopterin as a marker for immune system activation. Curr Drug Metab 2002, 3:175-187
25. Weiss G, Kronberger P, Conrad F, Bodner E, Wachter H, Reibnegger G: Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res 1993, 53:260-265
26. Kronberger P, Weiss G, Tschmelitsch J, Fuchs D, Salzer GM, Wachter H, Reibnegger G: Predictive value of urinary neopterin in patients with lung cancer. Eur J Clin Chem Clin Biochem 1995, 33:831-837
27. Murr C, Bergant A, Widschwendter M, Heim K, Schrocksnadel H, Fuchs D: Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem 1999, 45:1998-2004
28. Melichar B, Solichova D, Svobodova I, Urbanek L, Vesely P, Melicharova K: Urinary neopterin in patients with liver tumors. Tumori 2006, 92:318-322 (Pubitemid 44525309)
29. Nanni S, Benvenuti V, Grasselli A, Priolo C, Aiello A, Mattiussi S, Colussi C, Lirangi V, Illi B, D'Eletto M, Cianciulli AM, Gallucci M, De Carli P, Sentinelli S, Mottolese M, Carlini P, Strigari L, Finn S, Mueller E, Arcangeli G, Gaetano C, Capogrossi MC, Donnorso RP, Bacchetti S, Sacchi A, Pontecorvi A, Loda M, Farsetti A: Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest 2009, 119:1093-1108
30. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992, 89:5547-5551
31. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL: Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995, 177:275-283
32. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S: Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 2002, 4:743-749
33. Zou MH, Shi C, Cohen RA: Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002, 109:817-826
34. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605
35. Ceylan-Isik AF, Guo KK, Carlson EC, Privratsky JR, Liao SJ, Cai L, Chen AF, Ren J: Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension 2009, 53:1023-1031
36. Downward J: The ras superfamily of small GTP-binding proteins. Trends Biochem Sci 1990, 15:469-472
37. Schubbert S, Shannon K, Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007, 7:295-308
38. Karnoub AE, Weinberg RA: Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008, 9:517-531
39. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 2001, 411:355-365
40. Vivanco I, Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2:489-501
41. Sakai K, Suzuki H, Oda H, Akaike T, Azuma Y, Murakami T, Sugi K, Ito T, Ichinose H, Koyasu S, Shirai M: Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase. J Biol Chem 2006, 281:17736-17742
42. Kolinsky MA, Gross SS: The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein. J Biol Chem 2004, 279:40677-40682
43. Xie L, Smith JA, Gross SS: GTP cyclohydrolase I inhibition by the prototypic inhibitor 2,4-diamino-6-hydroxypyrimidine: mechanisms and unanticipated role of GTP cyclohydrolase I feedback regulatory protein. J Biol Chem 1998, 273:21091-21098
44. Ikemoto K, Matsumoto T, Ohtsuki M, Itoh M, Tada S, Udagawa Y, Sumi-Ichinose C, Kondo K, Nomura T: 2,4-Diamino-6-hydroxypyrimidine (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH(4)-independent manner. Biochim Biophys Acta 2008, 1780:960-965
45. Tanaka K, Kaufman S, Milstien S: Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells, Proc Natl Acad Sci USA 1989, 86:5864-5867
46. Kerler F, Ziegler I, Schmid C, Bacher A: Synthesis of tetrahydrobiopterin in Friend erythroleukemia cells and its modulator effect on cell proliferation. Exp Cell Res 1990, 189:151-156
47. Anastasiadis PZ, Bezin L, Imerman BA, Kuhn DM, Louie MC, Levine RA: Tetrahydrobiopterin as a mediator of PC12 cell proliferation induced by EGF and NGF. Eur J Neurosci 1997, 9:1831-1837
48. Kashiwagi S, Tsukada K, Xu L, Miyazaki J, Kozin SV, Tyrrell JA, Sessa WC, Gerweck LE, Jain RK, Fukumura D: Perivascular nitric oxide gradients normalize tumor vasculature. Nat Med 2008, 14:255-257
49. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:E14-E22